FDA Output
FDA Output, May 2025
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in May 2025. Updated May 13, 2025.
Welcome to MyStrategist
Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways
Start Trial
Investors & Dealmaking
MedTech Capital Matters April 2025
We present selected private financings for February and March and this month's VC snapshot features early-stage medtech investor Nina Capital.
Don't Just Advertise... Strategize!
Advertise with MedTech Strategist and be seen by medtech's most influential executives.
Learn More
ICYMI
The Challenge of Women’s Health Reimbursement
Reimbursement strategies are key to succeeding in the growing, underserved market for women’s health technologies. Excerpted from our recent feature, The Business Case for Investing in Women’s Health.